Physician profile
Christopher A Yopp
NPI 1588907430
$13,297.58
in general payments reported to CMS, 2019-2025
17 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $812 · 2021: $139 · 2022: $6,055 · 2023: $2,968 · 2024: $1,969 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,385 · Education: $901 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,384.87 |
| Education | $900.88 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,967.35 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Nevro Corp. | $2,455.62 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $2,143.68 | 2022-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $1,527.99 | 2022-2023 | Intracept |
| Painteq LLC | $1,212.83 | 2023-2024 | Painteq |
| Spr Therapeutics, INC | $803.19 | 2022-2024 | Sprint Pns System |
| Medtronic USA, INC. | $543.60 | 2019 | |
| Medtronic, INC. | $407.33 | 2022-2025 | Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $359.76 | 2019-2024 | Proclaim |
| Globus Medical, INC. | $289.81 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $188.62 | 2024-2025 | |
| Biotronik Nro, INC. | $173.44 | 2024 | Prospera |
| Nalu Medical, INC. | $76.05 | 2022-2024 | Nalu Neurostimulation System |
| Abbvie INC. | $55.26 | 2022-2023 | Botox |
| Vertos Medical, INC. | $33.71 | 2023 | Mild Device Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $30.72 | 2025 | Reactiv8 |
| Averitas Pharma INC. | $28.62 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Yopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.